Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.
Identifying the targets of broadly neutralizing antibodies to HIV-1 and understanding how these antibodies develop remain important goals in the quest to rationally develop an HIV-1 vaccine. We previously identified a participant in the CAPRISA Acute Infection Cohort (CAP257) whose plasma neutralize...
Main Authors: | Constantinos Kurt Wibmer, Jinal N Bhiman, Elin S Gray, Nancy Tumba, Salim S Abdool Karim, Carolyn Williamson, Lynn Morris, Penny L Moore |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-10-01
|
Series: | PLoS Pathogens |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24204277/pdf/?tool=EBI |
Similar Items
-
Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.
by: Penny L Moore, et al.
Published: (2009-09-01) -
Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies.
by: Cathrine Scheepers, et al.
Published: (2022-09-01) -
Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development
by: Delphine C. Malherbe, et al.
Published: (2020-06-01) -
Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
by: Dieter Mielke, et al.
Published: (2019-12-01) -
The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes.
by: Hongjun Bai, et al.
Published: (2019-06-01)